|
2024
|
Invention
|
Genetically modified immune cells for the treatment of tumors and autoimmune diseases. The presen... |
|
|
G/S
|
Interactive electronic publications; Downloadable publications; Podcasts; Downloadable video reco... |
|
|
Invention
|
Mirna inhibitor for the treatment of bone loss diseases. The present invention concerns an inhibi... |
|
|
Invention
|
Gd2-specific chimeric antigen receptor effector cells for use in the treatment of solid tumors, p... |
|
|
Invention
|
Method for the calculation of the adverse prognoses risk score in respiratory viral disease infec... |
|
|
Invention
|
Product comprising an aptamer conjugated to the edited mirna mir-589-3p and medical uses thereof.... |
|
2023
|
Invention
|
Igg derived b7-h3-specific chimeric antigen receptor (b7-h3 car) effector cells for the treatment... |
|
|
Invention
|
Igm derived b7-h3-specific chimeric antigen receptor (b7-h3 car) effector cells for the treatment... |
|
|
Invention
|
Gamma-secretase inhibitors for use in the treatment of inherited epidermolysis bullosa. The prese... |
|
2022
|
Invention
|
Antigen cd111 as a new specific diagnostic and therapeutic marker for polymorphonuclear myeloid-d... |
|
|
Invention
|
Method for the in vitro diagnosis of neurogenerative metabolic diseases.
The present invention c... |
|
|
Invention
|
Method for the in vitro diagnosis of neurogenerative metabolic diseases. The present invention co... |
|
|
G/S
|
Education services relating to medicine; Publication of medical texts. Development of pharmaceuti... |
|
|
Invention
|
Device for the treatment of esophageal atresias and stenosis.
A device for the treatment of esop... |
|
|
Invention
|
Device for the treatment of esophageal atresias and stenosis. The device (1) for the treatment of... |
|
2021
|
Invention
|
Car t cells for treating cd19+, cd20+ or cd22+ tumors or b-cell derived auto-immune diseases.
CA... |
|
|
Invention
|
Car t cells for treating cd19+, cd20+ or cd22+ tumors or b-cell derived auto-immune diseases. The... |
|
|
Invention
|
Method for determining whether a cell shown in a nuclear fluorescence image acquired through conf... |
|
|
Invention
|
Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for making a... |
|
|
Invention
|
Peptides able to bind angiotensin-converting enzyme 2 (ace2) and medical uses thereof. The presen... |
|
|
Invention
|
Peptides targeting shp2 and uses thereof.
The present invention relates to a peptide having the ... |
|
|
Invention
|
Peptides targeting shp2 and uses thereof. 211234521135244 are anionic amino acids, preferably eac... |
|
2020
|
Invention
|
Circulating micro-rnas as biomarkers for the diagnosis of celiac disease and for monitoring adher... |
|
|
Invention
|
Car-cd123 vector and uses thereof.
The present invention relates to a chimeric antigen receptor ... |
|
|
Invention
|
Car-cd123 vector and uses thereof. The present invention relates to a chimeric antigen receptor (... |
|
2019
|
Invention
|
Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufact... |
|
|
Invention
|
Use of snp rs17618244 as a predictive marker in nonalcoholic fatty liver disease (nafld). The pre... |
|
|
Invention
|
Short interfering rna targeting variant c1858t of gene ptpn22. The present invention concerns a s... |
|
|
Invention
|
Methods for treating cancer by targeting nidogen-1. This invention relates to methods of treating... |
|
|
Invention
|
Car-cd30 t cells for treatment of cd30+ tumors. A third generation of CAR-CD30 T cells is for tre... |
|
|
Invention
|
Car-cd30 t cells for treatment of cd30+ tumors. The present invention concerns a third generation... |
|
|
G/S
|
Pharmaceutical preparations, namely, antidepressants, anti-diabetic pharmaceuticals, anti-epilept... |
|
2018
|
G/S
|
Pharmaceutical preparations for treating sunburn, for skin care, for the treatment of hyperlipide... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
2017
|
Invention
|
Diagnosis and therapy of ankylosing spondylitis. The present invention relates to synthetic or re... |
|
|
Invention
|
Metagenomic method for in vitro diagnosis of gut dysbiosis.
The present invention concerns a met... |
|
|
Invention
|
Metagenomic method for in vitro diagnosis of gut dysbiosis. The present invention concerns a meta... |
|
|
Invention
|
System and method for experimental determination of dosimetric quantities with ct scanners. In a ... |
|
2015
|
Invention
|
Device for the treatment of esophageal stenoses. A device for the treatment of esophageal stenose... |
|
|
Invention
|
Device for the treatment of esophageal stenoses. The device (1) for the treatment of esophageal s... |
|
2014
|
G/S
|
Training courses in the medical and health sector. Medical and bacteriology laboratories. Hospitals. |
|
2012
|
Invention
|
Microvesicles isolated from mesenchymal stem cells for use as immunosuppressive agents. The prese... |
|
|
Invention
|
Device for the treatment of esophageal stenosis. The device (1) for the treatment of oesophageal ... |
|
|
Invention
|
Use of at least one p75ntr receptor inhibitor, alone or in association with at least one trka rec... |
|
2009
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetica... |
